Your browser doesn't support javascript.
loading
Messenger RNA electroporated hepatitis B virus (HBV) antigen-specific T cell receptor (TCR) redirected T cell therapy is well-tolerated in patients with recurrent HBV-related hepatocellular carcinoma post-liver transplantation: results from a phase I trial.
Yang, Fan; Zheng, Xiaofang; Koh, Sarene; Lu, Jianxi; Cheng, Jintao; Li, Panlong; Du, Cong; Chen, Yunhao; Chen, Xiaoyan; Yang, Li; Chen, Wanxin; Wong, Regina Wanju; Wai, Lu-En; Wang, Tingting; Zhang, Qi; Chen, Wenjie.
Afiliación
  • Yang F; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Zheng X; Department of Infectious Diseases, The First People's Hospital of Kashi, The Kashi Affiliated Hospital, Sun Yat-Sen University, Kashi, 844000, China.
  • Koh S; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Lu J; Lion TCR Pte Ltd, Singapore, Singapore.
  • Cheng J; Agency for Science and Technology (A*STAR), Singapore Immunology Network, Singapore, Singapore.
  • Li P; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Du C; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Chen Y; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Chen X; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Yang L; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Chen W; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Wong RW; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Wai LE; Biotherapy Centre, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, China.
  • Wang T; Lion TCR Pte Ltd, Singapore, Singapore.
  • Zhang Q; Lion TCR Pte Ltd, Singapore, Singapore.
  • Chen W; Agency for Science and Technology (A*STAR), Singapore Immunology Network, Singapore, Singapore.
Hepatol Int ; 17(4): 850-859, 2023 Aug.
Article en En | MEDLINE | ID: mdl-37067675
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Hígado / Carcinoma Hepatocelular / Hepatitis B / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: Hepatol Int Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trasplante de Hígado / Carcinoma Hepatocelular / Hepatitis B / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Adult / Humans / Middle aged Idioma: En Revista: Hepatol Int Año: 2023 Tipo del documento: Article País de afiliación: China